Mindfulness-Based Groups Tied to Significant Reduction in Opioid Craving
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 29, 2025 -- For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support group for opioid use, substance use, and reductions in anxiety, but demonstrates a larger reduction in craving, according to a study published online Jan. 21 in JAMA Network Open.
Zev Schuman-Olivier, M.D., from Cambridge Health Alliance in Malden, Massachusetts, and colleagues compared the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) versus active control among adults receiving buprenorphine for OUD in a randomized clinical trial. The M-ROCC program was a 24-week motivationally adaptive, trauma-informed, mindfulness-based group curriculum; each week, participants attended an informal check-in and intervention. The recovery support control group curriculum used four evidence-based substance use disorder-focused nonmindfulness approaches.
The study included 196 participants. The researchers found that opioid use did not differ significantly between the groups (13.4 and 12.7 percent in the M-ROCC and recovery support groups, respectively); no significant differences were seen in cocaine or benzodiazepine use. Across both M-ROCC and recovery support groups, anxiety T scores were reduced, with no significant difference observed between the groups from baseline to week 24. Compared with recovery support group participants, the M-ROCC participants demonstrated a significantly larger reduction in opioid craving.
"The study suggests that mindfulness-based groups may be particularly useful for reducing craving among patients with OUD who are experiencing residual opioid craving during buprenorphine treatment," the authors write.
One author disclosed ties to Alkermes.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Stigma of Substance Use Disorder Varies by Condition, Provider
WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
Substance Use Disorder Linked to Higher Risk for Unplanned Readmissions
TUESDAY, July 29, 2025 -- People with any type of substance use disorder (SUD) face a higher risk for having an unplanned, 30-day hospital readmission compared with those without...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.